Published in Mol Cell Biol on February 26, 2007
Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer (2009) 1.98
The molecular machinery of myelin gene transcription in Schwann cells. Glia (2008) 1.91
Molecular mechanisms of inherited demyelinating neuropathies. Glia (2008) 1.68
The PMP22 gene and its related diseases. Mol Neurobiol (2012) 1.53
Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol (2010) 1.48
Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res (2010) 1.38
Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol (2007) 1.04
Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res (2012) 1.03
NF-κB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci (2013) 0.98
Developmental regulation of microRNA expression in Schwann cells. Mol Cell Biol (2011) 0.98
Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements. J Biol Chem (2009) 0.97
Regulation of the PMP22 gene through an intronic enhancer. J Neurosci (2011) 0.96
The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination. J Neurosci (2012) 0.95
SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium. J Biol Chem (2010) 0.95
Differential regulation of NAB corepressor genes in Schwann cells. BMC Mol Biol (2007) 0.94
Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations. Neurogenetics (2007) 0.93
Dynamic regulation of Schwann cell enhancers after peripheral nerve injury. J Biol Chem (2015) 0.92
Transcription factor SOX9 plays a key role in the regulation of visual cycle gene expression in the retinal pigment epithelium. J Biol Chem (2014) 0.92
Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes. J Neurochem (2010) 0.91
Differential Sox10 genomic occupancy in myelinating glia. Glia (2015) 0.90
Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation. Neurogenetics (2012) 0.89
Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22. Hum Mol Genet (2011) 0.88
Microprocessor Complex Subunit DiGeorge Syndrome Critical Region Gene 8 (Dgcr8) Is Required for Schwann Cell Myelination and Myelin Maintenance. J Biol Chem (2015) 0.85
SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression. PLoS One (2013) 0.82
A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo. PLoS One (2010) 0.82
Knockout of TLR4 and TLR2 impair the nerve regeneration by delayed demyelination but not remyelination. J Biomed Sci (2013) 0.80
MicroRNA and transcriptional crosstalk in myelinating glia. Neurochem Int (2014) 0.80
Temporal Analysis of Gene Expression in the Murine Schwann Cell Lineage and the Acutely Injured Postnatal Nerve. PLoS One (2016) 0.78
Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany NY) (2017) 0.75
Mpz gene suppression by shRNA increases Schwann cell apoptosis in vitro. Neurol Sci (2010) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res (2002) 7.33
The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev (2001) 4.40
Krox-20 controls myelination in the peripheral nervous system. Nature (1994) 4.04
Sox10, a novel transcriptional modulator in glial cells. J Neurosci (1998) 3.96
Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet (2000) 3.82
Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet (2004) 2.82
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci U S A (2005) 2.29
Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev (2002) 2.24
Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development (2001) 2.20
Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet (1998) 2.17
Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem (1998) 2.15
Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol (2000) 2.11
EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron (2001) 2.08
The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res (2000) 1.91
The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res (2006) 1.64
Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J Cell Biol (2004) 1.60
Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep (2006) 1.56
The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci (1996) 1.54
Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci (2005) 1.53
Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development (1999) 1.50
Secrets to a healthy Sox life: lessons for melanocytes. Pigment Cell Res (2005) 1.41
Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet (2001) 1.37
Direct regulation of myelin protein zero expression by the Egr2 transactivator. J Biol Chem (2005) 1.36
Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J Biol Chem (1998) 1.36
Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development (2002) 1.33
Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet (1995) 1.33
Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology (1999) 1.23
Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res (2002) 1.22
In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J Neurochem (2006) 1.19
Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J Neurochem (2005) 1.17
Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet (1999) 1.16
A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene. J Biol Chem (2000) 1.15
A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. Eur J Neurosci (1999) 1.14
In vitro and in vivo differentiation of boundary cap neural crest stem cells into mature Schwann cells. Exp Neurol (2006) 1.12
The Ddx20/DP103 dead box protein represses transcriptional activation by Egr2/Krox-20. J Biol Chem (2003) 1.11
Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control. Development (2003) 1.08
Biochemical and cellular properties of three immortalized Schwann cell lines expressing different levels of the myelin-associated glycoprotein. J Neurochem (1994) 1.04
Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction. Ann Neurol (2004) 0.99
Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells. Mol Cell Neurosci (2003) 0.98
Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling. J Biol Chem (2002) 0.97
Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve. Brain Res Mol Brain Res (1990) 0.93
Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology (2000) 0.92
Activation of myelin genes during transdifferentiation from melanoma to glial cell phenotype. J Biol Chem (2003) 0.92
A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease. Hum Mutat (1999) 0.91
Multiple regulatory elements control transcription of the peripheral myelin protein zero gene. J Biol Chem (1997) 0.90
A double point mutation in the DNA-binding region of Egr2 switches its function from inhibition to induction of proliferation: A potential contribution to the development of congenital hypomyelinating neuropathy. Neurobiol Dis (2006) 0.86
Novel EGR2 mutation R359Q is associated with CMT type 1 and progressive scoliosis. Neuromuscul Disord (2005) 0.83
Different consequences of EGR2 mutants on the transactivation of human Cx32 promoter. Neurobiol Dis (2003) 0.80
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. Neurobiol Dis (2001) 0.80
HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nat Neurosci (2011) 1.67
Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci (2005) 1.53
MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes. PLoS Biol (2013) 1.45
Direct regulation of myelin protein zero expression by the Egr2 transactivator. J Biol Chem (2005) 1.36
Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate. Cancer Res (2008) 1.30
NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex. J Biol Chem (2006) 1.28
In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J Neurochem (2006) 1.19
Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J Neurochem (2005) 1.17
Neurokinin-B transcription in erythroid cells: direct activation by the hematopoietic transcription factor GATA-1. J Biol Chem (2004) 1.17
Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat Neurosci (2010) 1.16
Active gene repression by the Egr2.NAB complex during peripheral nerve myelination. J Biol Chem (2008) 1.13
The Ddx20/DP103 dead box protein represses transcriptional activation by Egr2/Krox-20. J Biol Chem (2003) 1.11
Associations between early life stress and gene methylation in children. Child Dev (2014) 1.08
Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem (2008) 1.07
Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol (2007) 1.04
SOX10 directly modulates ERBB3 transcription via an intronic neural crest enhancer. BMC Dev Biol (2011) 1.03
Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res (2012) 1.03
Differential requirement for Lck during primary and memory CD8+ T cell responses. Proc Natl Acad Sci U S A (2006) 1.02
A loss of insulin-like growth factor-2 imprinting is modulated by CCCTC-binding factor down-regulation at senescence in human epithelial cells. J Biol Chem (2004) 1.00
Functional dissection of the Oct6 Schwann cell enhancer reveals an essential role for dimeric Sox10 binding. J Neurosci (2011) 0.99
Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X(7). J Leukoc Biol (2002) 0.99
Developmental regulation of microRNA expression in Schwann cells. Mol Cell Biol (2011) 0.98
Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements. J Biol Chem (2009) 0.97
Regulation of the PMP22 gene through an intronic enhancer. J Neurosci (2011) 0.96
Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity. J Immunol (2007) 0.95
The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination. J Neurosci (2012) 0.95
Differential regulation of NAB corepressor genes in Schwann cells. BMC Mol Biol (2007) 0.94
Regulation of memory CD8 T-cell differentiation by cyclin-dependent kinase inhibitor p27Kip1. Mol Cell Biol (2010) 0.93
Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes. J Neurochem (2010) 0.91
A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate. Prostate (2008) 0.90
Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22. Hum Mol Genet (2011) 0.88
Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression. J Biol Chem (2011) 0.88
Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol (2013) 0.88
Identification of drug modulators targeting gene-dosage disease CMT1A. ACS Chem Biol (2012) 0.87
SOX10 regulates expression of the SH3-domain kinase binding protein 1 (Sh3kbp1) locus in Schwann cells via an alternative promoter. Mol Cell Neurosci (2011) 0.86
Use of real-time reverse transcriptase polymerase chain reaction assay and cell culture methods for detection of swine influenza A viruses. Am J Vet Res (2005) 0.80
Genome editing-enabled HTS assays expand drug target pathways for Charcot-Marie-tooth disease. ACS Chem Biol (2014) 0.80
CD8 T cell responses to lymphocytic choriomeningitis virus in early growth response gene 1-deficient mice. J Immunol (2004) 0.78
Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies. Neurogenetics (2002) 0.78
Role of cell cycle regulator E2F1 in regulating CD8 T cell responses during acute and chronic viral infection. Virology (2004) 0.76
Identification of equine P-selectin glycoprotein ligand-1 (CD162). Mamm Genome (2005) 0.75
Role of cell cycle regulator p19ARF in regulating T cell responses. Cell Immunol (2002) 0.75